North America
Diabetes
Market Overview 2024-2028
October 2024
North America Diabetes Market Overview
Table of Content
1 Market Overview
2 Diabetes Market Segmentation
2.1 Type 1 Diabetes
2.2 Type 2 Diabetes
2.3 Gestational Diabetes
3 Competitive Landscape
3.1.1 Company Overview
3.1.2 Product and Service Portfolio
3.2.1 Company Overview
3.2.2 Product and Service Portfolio
3.3.1 Company Overview
3.3.2 Product and Service Portfolio
3.4.1 Company Overview
© [Link] 2024. All rights reserved.
North America Diabetes Market Overview
3.4.2 Product and Service Portfolio
3.5.1 Company Overview
3.5.2 Product and Service Portfolio
3.1 Novo Nordisk
3.2 Sanofi
3.3 Eli Lilly and Company
3.4 Medtronic
3.5 Dexcom
4 Value Chain Analysis
5 Additional Resources
© [Link] 2024. All rights reserved.
North America Diabetes Market Overview
1 Market Overview
The North American region has been witnessing a significant increase in the
prevalence of diabetes, which has generated a growing demand for diabetes
devices. This can be attributed to various factors such as sedentary lifestyles,
unhealthy food habits, and an aging population. Consequently, the Diabetes
Devices Market in North America is expected to reach USD 10.96 billion by 2027.
An array of innovative products are emerging within the diabetes devices market,
encompassing glucose monitoring devices, insulin delivery devices, and other
associated technologies. Continuous Glucose Monitoring (CGM) devices, for
instance, have gained prominence due to their ability to provide real-time glucose
readings, thereby enabling better diabetes management. Additionally, insulin
pumps have increasingly become a preferred method for administering insulin, as
they offer more precise and consistent dosages compared to traditional
injections.
Another factor contributing to the growth of this market is the increasing
awareness and knowledge about diabetes among the general population. Various
government and non-profit organizations are actively undertaking initiatives to
educate people about the importance of early diagnosis, prevention, and
effective management of diabetes. Moreover, advancements in telemedicine and
© [Link] 2024. All rights reserved.